Jacques Mallet
Director/Miembro de la Junta en VALERIO THERAPEUTICS .
Origen de la red de primer grado Jacques Mallet.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
Evolva SA
 Evolva SA Miscellaneous Commercial ServicesCommercial Services Evolva SA is a Swiss-headquartered, international pharmaceutical biotech company focused on the discovery and development of drugs based on its distinctive and proprietary genetic chemistry platform. The company was founded in Switzerland in 2004 based on US/Danish technology. Evolva is headquartered in Allschwil/Basel with operations in Denmark, India and the USA. The Company has raised CHF 38.2 million of equity to date and employs 75 persons of whom 30 are based in Allschwil. The firm's strategy and business approach is based on five pillars that offer a sustainable development path for creating a successful company, which include Building a balanced portfolio. Evolva focuses on orally available small molecules in the belief that they are more convenient for patients and more cost-effective both from manufacture and administration points of view for the society, focus on differentiated pharmaceutical products with major benefits. Focusing on cardiovascular/renal and infectious diseases. Together they cause more than 50% of all deaths worldwide. Most of the top 20 pharmaceutical companies are active in both sectors, and all are active in one of the two sectors - hence widening Evolva's opportunities to partner. Building technology platform as the source of this differentiation. Evolva finds different structures with different properties from those found by the 99% of the industry that focuses on synthetic chemistry or proteins. Openness to unusual markets. The biotech business model has changed. As well as the established markets new opportunities arise in emerging countries such as India and China, and in adjacent sectors such as treatments against potential bio-terrorist and bio-warfare agents and the production of pharmaceutical and industrial chemical intermediates. Cost-effective implementation. Evolva places different functions around the globe according to where local conditions best suit. This approach both reduces Evolva's cost base and increases access to revenues, partners and talent. Evolva sees revenues and partners as important because they provide additional flexibility, resources and talent. Also, they provide important opportunities to better understand, and better meet, the needs of current and future customers.
15
| Subsidiary | Miscellaneous Commercial Services | 15 |
| Public Company | Pharmaceuticals: Major | 15 | |
Isocell SA
 Isocell SA Food RetailRetail Trade Isocell SA operates as a holding company with interests in the manufacture of food supplements. It develops proprietary formulation for super-oxyde dismutase. The firm also targets food areas including sodas, sport drinks and dairies with wellness claims. It also engages in the ownership and operations of medical laboratories. The company was founded by Francois Vix on July 9, 2001 and is headquartered in Paris, France.
8
| Holding Company | Food Retail | 8 |
Auriga Partners SA
 Auriga Partners SA Investment ManagersFinance Auriga Partners SA (Auriga) is an independent, management-owned venture capital firm which was founded by Patrick Bamas, Jacques Chatain and Bernard Daugeras in 1998. Headquartered in Paris, the firm's core activity is enterprise creation. In addition to providing a network of contacts capable of accelerating internationalization, and furthering strategic partnerships and business deals, Auriga manages several seed and early-stage funds specializing in information technology and life sciences.
3
| Private Company | Investment Managers | 3 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Jacques Mallet a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| GERON CORPORATION | Biotechnology | Director/Board Member General Counsel | |
| Aventis, Inc. | Corporate Officer/Principal Comptroller/Controller/Auditor | ||
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Technical University of Denmark | College/University | Graduate Degree Doctorate Degree | |
Domain Therapeutics SA
 Domain Therapeutics SA BiotechnologyHealth Technology Domain Therapeutics SA discovers and develops drug candidates targeting G-protein coupled receptors (GPCR) in all major therapeutic fields. The firm?s products include technologies, such as DTect-All and BioSens-All. Its services encompass allosteric modulators identification, biased ligands selection, orphan and historically intractable GPCRs address and high throughput screening campaign. The company was founded by Maurice Isra?l, Pierre Potier, Bernard Jacques Alex Gilly, Yves Dunant and Pascal Neuville in 2008 and is headquartered in Illkirch-Graffenstaden, France. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Elaia Partners SAS
 Elaia Partners SAS Investment ManagersFinance Elaia Partners SAS (Elaia) is an independent French private equity boutique which was founded in 2002. Named after the Greek word for olive tree, the symbol of resilience, longevity and prosperity, Elaia focuses on software technology companies. The firm is headquartered in Paris and manages Elaia Ventures, a French FCPR fund backed by financial institutions, industrial investors and family offices. | Investment Managers | Private Equity Investor Private Equity Investor | |
| EKINOPS | Telecommunications Equipment | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| MEDIAN TECHNOLOGIES | Medical/Nursing Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Aveni SA
 Aveni SA Chemicals: Major DiversifiedProcess Industries Aveni SA designs, develops, manufactures and markets chemical formulations. It enables future technologies with its approach to metallization for semiconductor, MEMS, advanced packaging, and flex applications. The company was founded in 2001 and is headquartered in Massy, France. | Chemicals: Major Diversified | Director/Board Member Director/Board Member Director/Board Member | |
Eptica SA
 Eptica SA Information Technology ServicesTechnology Services Eptica SA provides online customer service software. It offers solution for customer interaction management including web self-service, social customer service, email management, chat, fax-letter-short message service, and knowledge management for customer service. The company was founded in 2001 and is headquartered in Boulogne-Billancourt, France. | Information Technology Services | Director/Board Member Director/Board Member Director/Board Member | |
| Eberhard Karls Universität Tübingen | College/University | Doctorate Degree Doctorate Degree | |
| University of Basel | College/University | Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
Aravis AG
 Aravis AG Investment ManagersFinance Aravis AG (Aravis) is an independent venture capital firm, founded in 2001 by Jean-Philippe Tripet and headquartered in Muttenz, Switzerland. | Investment Managers | Founder Private Equity Investor | |
| SYMETIS SA | Biotechnology | Director/Board Member Director/Board Member | |
| SUPERSONIC IMAGINE | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| École des Hautes Études Commerciales de Paris | College/University | Undergraduate Degree Masters Business Admin | |
EVE SA
 EVE SA Computer PeripheralsElectronic Technology EVE SA provides electrical installation work on public roads. The company was founded in April 2000 and is headquartered in Paris, France. | Computer Peripherals | Director/Board Member Director/Board Member | |
S*BIO Pte Ltd.
 S*BIO Pte Ltd. Pharmaceuticals: MajorHealth Technology S*BIO is a privately-held biotech company focused on the research and clinical development of novel targeted small molecule drugs for the treatment of cancer with leading programs around histone deacetylases (HDAC) and kinases. S*BIO's lead candidate, SB939, entered the clinic in 2007. SB1518, S*BIO's potent and orally-active JAK2 inhibitor, entered the clinic in 2008 and has received orphan drug designation from the U.S. FDA. S*BIO has entered into a development collaboration, and option & license agreement with Onyx Pharmaceuticals, Inc. to develop and commercialize SB1518 and its other novel JAK2 inhibitor, SB1578. S*BIO's SB1317, a novel multikinase inhibitor, is in pre-clinical development and under a worldwide exclusive license with Tragara Pharmaceuticals, Inc. for its development and commercialization. In line with its vision to be a leading fully-integrated oncology-focused biotech company in Asia Pacific, S*BIO has established a state-of-the-art R&D infrastructure, complemented by a strong clinical development team. S*BIO has strong links with a network of medical oncologists in Asia Pacific and its investors include EDB Investments' biomedical sciences subsidiary Bio*One Capital, Aravis Ventures, Novartis Bioventures and other international funds. In 2009, S*BIO received the BioSpectrum Editor's Choice, Emerging BioScience Company of Singapore Award. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Availpro SAS
 Availpro SAS Other Consumer ServicesConsumer Services Availpro SAS provides online hotel reservation solutions. It offers a booking engine, which is integrated with a distribution tool, allowing the hoteliers to advertise and sell their rooms on third party websites. The company was founded by Philippe Jean Pierre Lamarche and Sébastien Maurice Boher on April 6, 2001 and is headquartered in Paris, France. | Other Consumer Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Tc Land Expression SA
 Tc Land Expression SA Miscellaneous Commercial ServicesCommercial Services Tc Land Expression SA operates as a molecular diagnostic company. It focuses on the development and commercialisation of tests aimed at monitoring patients with immunological conditions. The firm specializes in the area of organ transplantation and immune mediated disorders. Its development programs encompass RA-INF-Dx, IMD Dx2, IMD Dx3, and L-TolX. The company was founded by Marina Guillet and Alain Huriez in November 2002 and is headquartered in Huningue, France. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
Sensimed SA
 Sensimed SA Medical SpecialtiesHealth Technology Sensimed SA develops non-invasive soft contact lens-based solutions. It offers solutions to monitor fluctuations in intraocular pressure continuously. The company was founded by Matteo Leonardi and Sacha Cerboni in 2003 and is headquartered in Lausanne, Switzerland. | Medical Specialties | Chairman Director/Board Member | |
| TXCELL | Miscellaneous Commercial Services | Chairman Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
AlchiMedics SA
 AlchiMedics SA Chemicals: Major DiversifiedProcess Industries AlchiMedics SA specializes in coating technologies via electrografting. Its products enables covalent adhesion of nano to micrometric polymer-based layers on surfaces. The firm designs, develops and implements electro-grafting technology for implantable biomedical applications. The company was founded in 2007 and is headquartered in Grenoble, France. | Chemicals: Major Diversified | Director/Board Member Director/Board Member | |
CYTOO SA
 CYTOO SA Medical SpecialtiesHealth Technology CYTOO SA operates as a contract research organization which develops physiological cell-based assays. It focuses on developing, manufacturing, and commercializing new technologies for cell analysis for life sciences research community. The company has offices in Bethesda and Grenoble. The company was founded by François Chatelain, Alexandra Fuchs and Jacques Lewiner in 2008 and is headquartered in Grenoble, France. | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Convertigo SA
 Convertigo SA Packaged SoftwareTechnology Services Convertigo SAS provides Internet related software. It delivers a secured and scalable disruptive all-in-one solution, integrating rapid cross platform mobile development tools and a powerful MBaaS covering challenging backend enablement, featuring a middleware optimized for mobility. The company was founded by Olivier Picciotto and Jean-Michel Cohen in 1994 and is headquartered in Orsay, France. | Packaged Software | Corporate Officer/Principal Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
BonitaSoft SA
 BonitaSoft SA Packaged SoftwareTechnology Services BonitaSoft SA develops open source software. It also provides open source business process management solutions. The firm's product, Bonita open solution, is an open source BPM solution that designs, develops, executes, and monitors business processes; Bonita Studio, a BPM notation solution for drawing processes graphically; and Bonita execution engine with Bonita open solution for integrating new services or BPM standards as they emerge. The company was founded by Rodrigue Le Gall, Charles Souillard, and Miguel Valdes-Faura in 2001 and is headquartered in Boulogne, France. | Packaged Software | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| EVOLVA HOLDING SA | Food: Specialty/Candy | Director/Board Member Chairman Founder Corporate Officer/Principal Director/Board Member Director/Board Member Chief Executive Officer | |
| SENSORION | Pharmaceuticals: Major | Chairman Director/Board Member | |
eXo Platform SAS
 eXo Platform SAS Packaged SoftwareTechnology Services eXo Platform SAS provides information technology products and services. Its offers private cloud hosting, professional services, on-demand services, services packages, and training. The company was founded by Benjamin Mestrallet in 2003 and is headquartered in Paris, France. | Packaged Software | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
iDbyMe SA
 iDbyMe SA Catalog/Specialty DistributionRetail Trade iDbyMe SA sells clothes online. It provides online shopping related services. The firm offers sweaters, short cardigans, long and short vests, shirts, leather jackets, tops, dresses and coats. It provides to its customers the possibility to submit their own clothing designs. The company is headquartered in Luxembourg. | Catalog/Specialty Distribution | Director/Board Member Director/Board Member | |
| AMOÉBA | Household/Personal Care | Director/Board Member Director/Board Member Director/Board Member | |
| THERANEXUS | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Fabentech SAS
 Fabentech SAS Medical/Nursing ServicesHealth Services Fabentech SAS developes immunotherapeutic solutions for emerging infectious diseases as well as for certain drug intoxications. Its products include infography development, Lassa(FBH-003) and other emerging diseases. The company was founded by Bertrand Lepine on June 5, 2009 and is headquartered in Lyon, France. | Medical/Nursing Services | Director/Board Member Director/Board Member Director/Board Member | |
| WALLIX GROUP | Packaged Software | Director/Board Member Director/Board Member | |
Nuevolution A/S
 Nuevolution A/S Miscellaneous Commercial ServicesCommercial Services Nuevolution A/S engages in research and experimental development on biotechnology. It produces and commercializes technologies for the manufacture of substances for use in the pharmaceutical industry by screening non-biological polymers and low-molecular substances. The company was founded on May 8, 2001 and is headquartered in Copenhagen, Denmark. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Pylote SA
 Pylote SA BiotechnologyHealth Technology Pylote SA conceives and develops mineral microspheres to sell solutions. Its products include mineral microspheres, material integration and pylote added. The company was founded by Loïc Marchin and is headquartered in Dremil-Lafage, France. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
EnobraQ SAS
 EnobraQ SAS Chemicals: Major DiversifiedProcess Industries EnobraQ SAS develops yeast for the production of chemical compounds. The company was founded on November 13, 2015 and is headquartered in Ramonville-Saint-Agne, France. | Chemicals: Major Diversified | Director/Board Member Director/Board Member Director/Board Member | |
Nosopharm SAS
 Nosopharm SAS Pharmaceuticals: MajorHealth Technology Nosopharm SAS operates as a biotechnology company. It develops an anti-infective drug platform that is based on the medicinal chemistry of a novel antibiotic class used to cure life-threatening multi-resistant hospital-acquired infections. The company was founded by Philippe Villain-Guillot and Maxime Gualtieri in February 2009 and is headquartered in Nimes, France. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
FlashCell SAS
 FlashCell SAS BiotechnologyHealth Technology FlashCell SAS produces lentiviral vectors to develop gene therapy and immunotherapy programs for therapeutic purposes. The company was founded on August 12, 2016 and is headquartered in Toulouse, France. | Biotechnology | Director/Board Member Director/Board Member | |
VitaDx International SAS
 VitaDx International SAS Medical SpecialtiesHealth Technology VitaDx International SAS develops a solution for early diagnosis of bladder cancer. It offers Fluorescence, a technology that can classify cancer cells as tumorous or healthy, and machine learning, a software analysis that used a set of mathematical techniques allowing algorithms to solve problems from data without being explicitly programmed. The company was founded by Allan Rodriguez in 2013 and is headquartered in Rennes, France. | Medical Specialties | Director/Board Member Director/Board Member | |
Synendos Therapeutics AG
 Synendos Therapeutics AG Medical SpecialtiesHealth Technology Synendos Therapeutics AG develops molecules for the treatment of anxiety and stress-related disorders. The company was founded by Andrea Chicca, Simon Russell and Jürg Gertsch in April 2019 and is headquartered in Allschwil, Switzerland. | Medical Specialties | Director/Board Member Chairman | |
| CELLNOVO | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member | |
| MILIBOO | Home Furnishings | Director/Board Member Director/Board Member Director/Board Member | |
Firalis SA
 Firalis SA BiotechnologyHealth Technology Firalis SA engages in the discovery and development of biomarker-based diagnostics. It offers biomarkers for drug safety, cardiovascular, inflammatory and autoimmune diseases. The firm offers a portfolio of biomarker-based diagnostic methods and provides customer-tailored biomarker solutions. The company was founded on July 8, 2008 by Hüseyin Firat and is headquartered in Huningue, France. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member |
Estadísticas
Internacional
| Francia | 35 |
| Suiza | 8 |
| Dinamarca | 5 |
| Estados Unidos | 3 |
| Alemania | 2 |
Sectorial
| Health Technology | 23 |
| Consumer Services | 6 |
| Technology Services | 6 |
| Electronic Technology | 4 |
| Process Industries | 4 |
Operativa
| Director/Board Member | 282 |
| Corporate Officer/Principal | 77 |
| Chairman | 27 |
| Chief Executive Officer | 22 |
| Private Equity Investor | 20 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Philippe Peltier | 45 |
| Søren Lemonius | 39 |
| Florian Denis | 35 |
| Sébastien Descarpentries | 29 |
| Franck Lescure | 28 |
| Bernard Daugeras | 23 |
| Simon Jules Nebel | 23 |
| Jean-Philippe Tripet | 20 |
| Neil Goldsmith | 19 |
| Thomas Videbaek | 16 |
| Erich Schlick | 15 |
| Khalil Barrage | 15 |
| Jutta Monika Heim | 12 |
| Jean Nicolas Trebouta | 12 |
| Philippe Maitre | 11 |
- Bolsa de valores
- Insiders
- Jacques Mallet
- Conexiones Empresas
